|
C5ORF25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.934600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.268200E-01 |
| Normal-vs-Stage2 |
6.333700E-02 |
| Normal-vs-Stage3 |
6.599000E-01 |
| Normal-vs-Stage4 |
5.525000E-01 |
| Stage1-vs-Stage2 |
5.568500E-02 |
| Stage1-vs-Stage3 |
9.666400E-01 |
| Stage1-vs-Stage4 |
3.535200E-01 |
| Stage2-vs-Stage3 |
9.542500E-02 |
| Stage2-vs-Stage4 |
3.213800E-02 |
| Stage3-vs-Stage4 |
3.667600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.883000E-01 |
| Normal-vs-AfricanAmerican |
6.485200E-01 |
| Normal-vs-Asian |
5.546200E-01 |
| Caucasian-vs-AfricanAmerican |
3.087200E-01 |
| Caucasian-vs-Asian |
1.933620E-01 |
| AfricanAmerican-vs-Asian |
9.657800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.430400E-01 |
| Normal-vs-Female |
2.255600E-01 |
| Male-vs-Female |
7.164400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.166200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.186640E-01 |
| Normal-vs-Age(61-80Yrs) |
6.977200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.963400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.140000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.490800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.721400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.284800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.677200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.484200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.962800E-01 |
| Classical-VS-Follicular |
2.003400E-04 |
| Classical-VS-Other |
4.241400E-01 |
| Classical-VS-Normal |
5.075200E-01 |
| Tall-VS-Follicular |
1.267850E-02 |
| Tall-VS-Other |
4.838800E-01 |
| Tall-VS-Normal |
9.114800E-01 |
| Follicular-VS-Other |
5.889400E-01 |
| Follicular-VS-Normal |
5.542500E-03 |
| Other-VS-Normal |
4.681400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.224810E-01 |
| Normal-vs-N1 |
9.930800E-01 |
| N0-vs-N1 |
2.803400E-01 |
|
|
